ViewRay, Inc. Logo

ViewRay, Inc.

6L9.F

(0.8)
Stock Price

0,03 EUR

-24.31% ROA

-82.44% ROE

-0.09x PER

Market Cap.

227.314.890,85 EUR

154.07% DER

0% Yield

-99.04% NPM

ViewRay, Inc. Stock Analysis

ViewRay, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

ViewRay, Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.09x), the stock offers substantial upside potential at a bargain price.

2 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

3 ROE

Negative ROE (-102.73%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (-35.51%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

5 DER

The company has a high debt to equity ratio (154%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

ViewRay, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

ViewRay, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

ViewRay, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

ViewRay, Inc. Revenue
Year Revenue Growth
2013 3.159.000
2014 0 0%
2015 10.390.000 100%
2016 22.237.000 53.28%
2017 34.042.000 34.68%
2018 80.962.000 57.95%
2019 87.782.000 7.77%
2020 57.017.000 -53.96%
2021 70.119.000 18.69%
2022 102.206.000 31.39%
2023 90.136.000 -13.39%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

ViewRay, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2013 8.780.000
2014 0 0%
2015 10.449.000 100%
2016 11.442.000 8.68%
2017 14.709.000 22.21%
2018 16.520.000 10.96%
2019 23.794.000 30.57%
2020 25.008.000 4.85%
2021 31.849.000 21.48%
2022 32.431.000 1.79%
2023 34.512.000 6.03%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

ViewRay, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2013 9.508.000
2014 0 0%
2015 21.685.000 100%
2016 23.503.000 7.74%
2017 31.375.000 25.09%
2018 50.113.000 37.39%
2019 65.717.000 23.74%
2020 61.729.000 -6.46%
2021 56.091.000 -10.05%
2022 52.437.000 -6.97%
2023 46.328.000 -13.19%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

ViewRay, Inc. EBITDA
Year EBITDA Growth
2013 -26.041.000
2014 0 0%
2015 -41.542.000 100%
2016 -44.685.000 7.03%
2017 -62.732.000 28.77%
2018 -68.695.000 8.68%
2019 -115.872.000 40.71%
2020 -104.601.000 -10.78%
2021 -105.807.000 1.14%
2022 -100.457.000 -5.33%
2023 -104.932.000 4.26%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

ViewRay, Inc. Gross Profit
Year Gross Profit Growth
2013 -5.028.000
2014 0 0%
2015 -4.154.000 100%
2016 -3.629.000 -14.47%
2017 6.332.000 157.31%
2018 6.603.000 4.1%
2019 -5.478.000 220.54%
2020 -4.059.000 -34.96%
2021 335.000 1311.64%
2022 10.045.000 96.67%
2023 -5.720.000 275.61%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

ViewRay, Inc. Net Profit
Year Net Profit Growth
2013 -27.222.000
2014 0 0%
2015 -44.995.000 100%
2016 -50.636.000 11.14%
2017 -72.176.000 29.84%
2018 -76.396.000 5.52%
2019 -120.199.000 36.44%
2020 -107.908.000 -11.39%
2021 -110.048.000 1.94%
2022 -107.330.000 -2.53%
2023 -115.436.000 7.02%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

ViewRay, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2013 -33
2014 0 0%
2015 -3 100%
2016 -1 -100%
2017 -1 0%
2018 -1 0%
2019 -1 100%
2020 -1 0%
2021 -1 0%
2022 -1 0%
2023 -1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

ViewRay, Inc. Free Cashflow
Year Free Cashflow Growth
2013 -27.069.000
2014 -24.349 -111070.89%
2015 -44.104.000 99.94%
2016 -35.199.000 -25.3%
2017 -72.216.000 51.26%
2018 -125.879.000 42.63%
2019 -87.384.000 -44.05%
2020 -69.657.000 -25.45%
2021 -63.650.000 -9.44%
2022 -95.606.000 33.42%
2023 -54.776.000 -74.54%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

ViewRay, Inc. Operating Cashflow
Year Operating Cashflow Growth
2013 -25.371.000
2014 -24.349 -104097.3%
2015 -39.849.000 99.94%
2016 -28.156.000 -41.53%
2017 -70.053.000 59.81%
2018 -122.194.000 42.67%
2019 -79.567.000 -53.57%
2020 -63.474.000 -25.35%
2021 -62.091.000 -2.23%
2022 -91.708.000 32.29%
2023 -53.599.000 -71.1%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

ViewRay, Inc. Capital Expenditure
Year Capital Expenditure Growth
2013 1.698.000
2014 0 0%
2015 4.255.000 100%
2016 7.043.000 39.59%
2017 2.163.000 -225.61%
2018 3.685.000 41.3%
2019 7.817.000 52.86%
2020 6.183.000 -26.43%
2021 1.559.000 -296.6%
2022 3.898.000 60.01%
2023 1.177.000 -231.18%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

ViewRay, Inc. Equity
Year Equity Growth
2013 3.029
2014 3.168 4.39%
2015 -6.957.000 100.05%
2016 -43.653.000 84.06%
2017 1.987.000 2296.93%
2018 167.309.000 98.81%
2019 216.174.000 22.6%
2020 130.266.000 -65.95%
2021 169.795.000 23.28%
2022 82.242.000 -106.46%
2023 55.257.000 -48.84%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

ViewRay, Inc. Assets
Year Assets Growth
2013 5.729
2014 10.448 45.17%
2015 52.157.000 99.98%
2016 48.764.000 -6.96%
2017 135.711.000 64.07%
2018 294.970.000 53.99%
2019 350.019.000 15.73%
2020 261.552.000 -33.82%
2021 321.807.000 18.72%
2022 271.397.000 -18.57%
2023 233.159.000 -16.4%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

ViewRay, Inc. Liabilities
Year Liabilities Growth
2013 2.700
2014 7.280 62.91%
2015 59.114.000 99.99%
2016 92.417.000 36.04%
2017 133.724.000 30.89%
2018 127.661.000 -4.75%
2019 133.845.000 4.62%
2020 131.286.000 -1.95%
2021 152.012.000 13.63%
2022 189.155.000 19.64%
2023 177.902.000 -6.33%

ViewRay, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.31
Net Income per Share
-0.31
Price to Earning Ratio
-0.09x
Price To Sales Ratio
3.97x
POCF Ratio
-0.07
PFCF Ratio
-2.91
Price to Book Ratio
0.09
EV to Sales
4.04
EV Over EBITDA
-4.47
EV to Operating CashFlow
-3.02
EV to FreeCashFlow
-2.96
Earnings Yield
-11.34
FreeCashFlow Yield
-0.34
Market Cap
0,23 Bil.
Enterprise Value
0,23 Bil.
Graham Number
1.46
Graham NetNet
-0.22

Income Statement Metrics

Net Income per Share
-0.31
Income Quality
1.35
ROE
-0.82
Return On Assets
-0.24
Return On Capital Employed
-0.84
Net Income per EBT
1
EBT Per Ebit
1.02
Ebit per Revenue
-0.97
Effective Tax Rate
-0.07

Margins

Sales, General, & Administrative to Revenue
0.44
Research & Developement to Revenue
0.29
Stock Based Compensation to Revenue
0.16
Gross Profit Margin
0.05
Operating Profit Margin
-0.97
Pretax Profit Margin
-0.99
Net Profit Margin
-0.99

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.42
Free CashFlow per Share
-0.43
Capex to Operating CashFlow
0.02
Capex to Revenue
-0.03
Capex to Depreciation
-0.69
Return on Invested Capital
-0.43
Return on Tangible Assets
-0.24
Days Sales Outstanding
303.14
Days Payables Outstanding
202.74
Days of Inventory on Hand
283.88
Receivables Turnover
1.2
Payables Turnover
1.8
Inventory Turnover
1.29
Capex per Share
-0.01

Balance Sheet

Cash per Share
0,45
Book Value per Share
0,30
Tangible Book Value per Share
0.3
Shareholders Equity per Share
0.3
Interest Debt per Share
0.49
Debt to Equity
1.54
Debt to Assets
0.37
Net Debt to EBITDA
-0.07
Current Ratio
1.16
Tangible Asset Value
0,06 Bil.
Net Current Asset Value
0,02 Bil.
Invested Capital
1.54
Working Capital
0,03 Bil.
Intangibles to Total Assets
0
Average Receivables
0,04 Bil.
Average Payables
0,03 Bil.
Average Inventory
36747500
Debt to Market Cap
0.37

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

ViewRay, Inc. Dividends
Year Dividends Growth

ViewRay, Inc. Profile

About ViewRay, Inc.

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. The company was founded in 2004 and is headquartered in Oakwood, Ohio.

CEO
Mr. Paul Ziegler Jr., J.D.
Employee
295
Address
2 Thermo Fisher Way
Oakwood, 44146

ViewRay, Inc. Executives & BODs

ViewRay, Inc. Executives & BODs
# Name Age
1 Karen Hackstaff
Vice President of Marketing
70
2 Dr. Martin Fuss M.D., Ph.D.
Chief Medical Officer
70
3 Mr. Sanket Shah J.D.
Senior Vice President & General Counsel
70
4 Mr. Adam Podbelski
Senior Vice President of Commercial Operations
70
5 Mr. Paul Ziegler Jr., J.D.
President, Chief Executive Officer & Director
70
6 Drew Hill
Senior Vice President of Operations & Development
70
7 Ms. Julianne Mast
Vice President of Human Resources
70
8 Dr. James F. Dempsey Ph.D.
Founder & Chief Scientific Officer
70
9 Mr. Jacob Edward Signoriello
Interim Chief Financial Officer
70
10 Matt Harrison
Director of Investor Relations
70

ViewRay, Inc. Competitors